Professors Could Lose Jobs for Housing Rare, Psychedelic Plant

Miami University’s plant conservatory was growing seedlings of iboga, which contains an illegal, psychoactive substance.

Written byKerry Grens
| 2 min read
Tabernanthe iboga Baill. psychedelic psychoactive

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: Tabernanthe iboga Baill.
WIKIMEDIA, JI-ELLE

The manager of the plant conservatory at Miami University in Ohio is out of a job, while its director, a biology professor, and an anthropology professor are set to be fired after authorities learned that the facility was growing several seedlings of a psychedelic plant called iboga, Inside Higher Ed reports. There is no indication that the researchers intended to cultivate the plant’s illegal, psychoactive substance, but a student who picked up several leftover seedlings reportedly wanted to “get high.”

Once the university learned of the student’s intention to grow the plant for illicit drug use, it alerted authorities and the Drug Enforcement Agency (DEA) confiscated the plant in November, but did not press charges against conservatory staff. A spokesperson for the agency tells Inside Higher Ed that research on narcotics classified as schedule 1 must be approved by DEA, but would not comment on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies